In vitro pharmacodynamic evaluation of antiviral medicinal plants using a vector-based assay technique
Aims: Medicinal plants are increasingly being projected as suitable alternative sources of antiviral agents. The development of a suitable in vitro pharmacodynamic screening technique could contribute to rapid identification of potential bioactive plants and also to the standardization and/or pharma...
Gespeichert in:
Veröffentlicht in: | Journal of applied microbiology 2005-01, Vol.99 (6), p.1346-1355 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1355 |
---|---|
container_issue | 6 |
container_start_page | 1346 |
container_title | Journal of applied microbiology |
container_volume | 99 |
creator | Esimone, C.O Grunwald, T Wildner, O Nchinda, G Tippler, B Proksch, P Uberla, K |
description | Aims: Medicinal plants are increasingly being projected as suitable alternative sources of antiviral agents. The development of a suitable in vitro pharmacodynamic screening technique could contribute to rapid identification of potential bioactive plants and also to the standardization and/or pharmacokinetic-pharmacodynamic profiling of the bioactive components. Methods and Results: Recombinant viral vectors (lentiviral, retroviral and adenoviral) transferring the firefly luciferase gene were constructed and the inhibition of viral vector infectivity by various concentrations of plant extracts was evaluated in HeLa or Hep2 cells by measuring the changes in luciferase activity. Cytotoxicity of the extracts was evaluated in parallel on HeLa or Hep2 cells stably expressing luciferase. Amongst the 15 extracts screened, only the methanol (ME) and the ethyl acetate (ET) fractions of the lichen, Ramalina farinacea specifically reduced lentiviral and adenoviral infectivity in a dose-dependent manner. Further, chromatographic fractionation of ET into four fractions (ET1-ET4) revealed only ET4 to be selectively antiviral with an IC50 in the 20 microgram ml(-1) range. Preliminary mechanistic studies based on the addition of the extracts at different time points in the viral infection cycle (kinetic studies) revealed that the inhibitory activity was highest if extract and vectors were preincubated prior to infection, suggesting that early steps in the lentiviral or adenoviral replication cycle could be the major target of ET4. Inhibition of wild-type HIV-1 was also observed at a 10-fold lower concentration of the extract. Conclusions: The vector-based assay is a suitable in vitro pharmacodynamic evaluation technique for antiviral medicinal plants. The technique has successfully demonstrated the presence of antiviral principles in R. farinacea. Significance and Impact of Study: Potential anti-HIV medicinal plants could rapidly be evaluated with the reported vector-based technique. The lichen, R. farinacea could represent a lead source of antiviral substances and is thus worthy of further studies. |
doi_str_mv | 10.1111/j.1365-2672.2005.02732.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68842064</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68842064</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5022-cf2ac87e341f8f8d02ff320baee46da729da356597332eac1f9cfb45a8a4c3b73</originalsourceid><addsrcrecordid>eNqNksFu1DAQhi0EoqXwCuAL3BLsseMkBw5VBaWoiAP0bE0cu_UqiRc7WbpvX6e7okfwxSP7-z3jf4YQylnJ8_q4KblQVQGqhhIYq0oGtYDy_hk5_Xvx_DGWRcVqOCGvUtowxgWr1EtywpXgQrL6lLirie78HAPd3mEc0YR-P-HoDbU7HBacfZhocBSn2e98xIGOtvfGTznaDvk00SX56ZYi3Vkzh1h0mGxPMSXc09mau8n_Xuxr8sLhkOyb435Gbr58_nXxtbj-cXl1cX5dmIoBFMYBmqa2QnLXuKZn4JwA1qG1UvVYQ9ujqFTV1kKARcNda1wnK2xQGtHV4ox8OLy7jSGnTbMefTJ2yJXasCStmkYCU_KfIG8bwZWEDDYH0MSQUrROb6MfMe41Z3ptht7o1XO9eq7XZujHZuj7LH17zLF02bUn4dH9DLw_ApgMDi7iZHx64vJ_BRNrDZ8O3B8_2P1_F6C_nX9fo6x_d9A7DBpvY85x8xPWaeB5OGQL4gHiu6_y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19831642</pqid></control><display><type>article</type><title>In vitro pharmacodynamic evaluation of antiviral medicinal plants using a vector-based assay technique</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Wiley Online Library All Journals</source><creator>Esimone, C.O ; Grunwald, T ; Wildner, O ; Nchinda, G ; Tippler, B ; Proksch, P ; Uberla, K</creator><creatorcontrib>Esimone, C.O ; Grunwald, T ; Wildner, O ; Nchinda, G ; Tippler, B ; Proksch, P ; Uberla, K</creatorcontrib><description>Aims: Medicinal plants are increasingly being projected as suitable alternative sources of antiviral agents. The development of a suitable in vitro pharmacodynamic screening technique could contribute to rapid identification of potential bioactive plants and also to the standardization and/or pharmacokinetic-pharmacodynamic profiling of the bioactive components. Methods and Results: Recombinant viral vectors (lentiviral, retroviral and adenoviral) transferring the firefly luciferase gene were constructed and the inhibition of viral vector infectivity by various concentrations of plant extracts was evaluated in HeLa or Hep2 cells by measuring the changes in luciferase activity. Cytotoxicity of the extracts was evaluated in parallel on HeLa or Hep2 cells stably expressing luciferase. Amongst the 15 extracts screened, only the methanol (ME) and the ethyl acetate (ET) fractions of the lichen, Ramalina farinacea specifically reduced lentiviral and adenoviral infectivity in a dose-dependent manner. Further, chromatographic fractionation of ET into four fractions (ET1-ET4) revealed only ET4 to be selectively antiviral with an IC50 in the 20 microgram ml(-1) range. Preliminary mechanistic studies based on the addition of the extracts at different time points in the viral infection cycle (kinetic studies) revealed that the inhibitory activity was highest if extract and vectors were preincubated prior to infection, suggesting that early steps in the lentiviral or adenoviral replication cycle could be the major target of ET4. Inhibition of wild-type HIV-1 was also observed at a 10-fold lower concentration of the extract. Conclusions: The vector-based assay is a suitable in vitro pharmacodynamic evaluation technique for antiviral medicinal plants. The technique has successfully demonstrated the presence of antiviral principles in R. farinacea. Significance and Impact of Study: Potential anti-HIV medicinal plants could rapidly be evaluated with the reported vector-based technique. The lichen, R. farinacea could represent a lead source of antiviral substances and is thus worthy of further studies.</description><identifier>ISSN: 1364-5072</identifier><identifier>EISSN: 1365-2672</identifier><identifier>DOI: 10.1111/j.1365-2672.2005.02732.x</identifier><identifier>PMID: 16313407</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science Ltd</publisher><subject>Adenoviridae Infections - drug therapy ; Adenoviruses, Human - genetics ; Adenoviruses, Human - physiology ; antiviral ; Antiviral Agents - therapeutic use ; antiviral properties ; Biological and medical sciences ; Biological Assay ; Cell Line, Tumor ; cultured cells ; cytotoxicity ; Fundamental and applied biological sciences. Psychology ; Genetic Engineering ; genetic vectors ; Genetic Vectors - administration & dosage ; Genetic Vectors - genetics ; HeLa Cells ; HIV - genetics ; HIV - physiology ; HIV Infections - drug therapy ; human health ; Human immunodeficiency virus ; Human immunodeficiency virus 1 ; Humans ; lichen ; Luciferases - genetics ; Luminescent Measurements ; medicinal plants ; Medicine, African Traditional ; Microbiology ; Nigeria ; pharmacodynamic ; pharmacology ; plant extracts ; Plant Extracts - therapeutic use ; Plants, Medicinal ; Ramalina farinacea ; Retroviridae - genetics ; Retroviridae - physiology ; vector‐based assay</subject><ispartof>Journal of applied microbiology, 2005-01, Vol.99 (6), p.1346-1355</ispartof><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5022-cf2ac87e341f8f8d02ff320baee46da729da356597332eac1f9cfb45a8a4c3b73</citedby><cites>FETCH-LOGICAL-c5022-cf2ac87e341f8f8d02ff320baee46da729da356597332eac1f9cfb45a8a4c3b73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1365-2672.2005.02732.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1365-2672.2005.02732.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17293032$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16313407$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Esimone, C.O</creatorcontrib><creatorcontrib>Grunwald, T</creatorcontrib><creatorcontrib>Wildner, O</creatorcontrib><creatorcontrib>Nchinda, G</creatorcontrib><creatorcontrib>Tippler, B</creatorcontrib><creatorcontrib>Proksch, P</creatorcontrib><creatorcontrib>Uberla, K</creatorcontrib><title>In vitro pharmacodynamic evaluation of antiviral medicinal plants using a vector-based assay technique</title><title>Journal of applied microbiology</title><addtitle>J Appl Microbiol</addtitle><description>Aims: Medicinal plants are increasingly being projected as suitable alternative sources of antiviral agents. The development of a suitable in vitro pharmacodynamic screening technique could contribute to rapid identification of potential bioactive plants and also to the standardization and/or pharmacokinetic-pharmacodynamic profiling of the bioactive components. Methods and Results: Recombinant viral vectors (lentiviral, retroviral and adenoviral) transferring the firefly luciferase gene were constructed and the inhibition of viral vector infectivity by various concentrations of plant extracts was evaluated in HeLa or Hep2 cells by measuring the changes in luciferase activity. Cytotoxicity of the extracts was evaluated in parallel on HeLa or Hep2 cells stably expressing luciferase. Amongst the 15 extracts screened, only the methanol (ME) and the ethyl acetate (ET) fractions of the lichen, Ramalina farinacea specifically reduced lentiviral and adenoviral infectivity in a dose-dependent manner. Further, chromatographic fractionation of ET into four fractions (ET1-ET4) revealed only ET4 to be selectively antiviral with an IC50 in the 20 microgram ml(-1) range. Preliminary mechanistic studies based on the addition of the extracts at different time points in the viral infection cycle (kinetic studies) revealed that the inhibitory activity was highest if extract and vectors were preincubated prior to infection, suggesting that early steps in the lentiviral or adenoviral replication cycle could be the major target of ET4. Inhibition of wild-type HIV-1 was also observed at a 10-fold lower concentration of the extract. Conclusions: The vector-based assay is a suitable in vitro pharmacodynamic evaluation technique for antiviral medicinal plants. The technique has successfully demonstrated the presence of antiviral principles in R. farinacea. Significance and Impact of Study: Potential anti-HIV medicinal plants could rapidly be evaluated with the reported vector-based technique. The lichen, R. farinacea could represent a lead source of antiviral substances and is thus worthy of further studies.</description><subject>Adenoviridae Infections - drug therapy</subject><subject>Adenoviruses, Human - genetics</subject><subject>Adenoviruses, Human - physiology</subject><subject>antiviral</subject><subject>Antiviral Agents - therapeutic use</subject><subject>antiviral properties</subject><subject>Biological and medical sciences</subject><subject>Biological Assay</subject><subject>Cell Line, Tumor</subject><subject>cultured cells</subject><subject>cytotoxicity</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genetic Engineering</subject><subject>genetic vectors</subject><subject>Genetic Vectors - administration & dosage</subject><subject>Genetic Vectors - genetics</subject><subject>HeLa Cells</subject><subject>HIV - genetics</subject><subject>HIV - physiology</subject><subject>HIV Infections - drug therapy</subject><subject>human health</subject><subject>Human immunodeficiency virus</subject><subject>Human immunodeficiency virus 1</subject><subject>Humans</subject><subject>lichen</subject><subject>Luciferases - genetics</subject><subject>Luminescent Measurements</subject><subject>medicinal plants</subject><subject>Medicine, African Traditional</subject><subject>Microbiology</subject><subject>Nigeria</subject><subject>pharmacodynamic</subject><subject>pharmacology</subject><subject>plant extracts</subject><subject>Plant Extracts - therapeutic use</subject><subject>Plants, Medicinal</subject><subject>Ramalina farinacea</subject><subject>Retroviridae - genetics</subject><subject>Retroviridae - physiology</subject><subject>vector‐based assay</subject><issn>1364-5072</issn><issn>1365-2672</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNksFu1DAQhi0EoqXwCuAL3BLsseMkBw5VBaWoiAP0bE0cu_UqiRc7WbpvX6e7okfwxSP7-z3jf4YQylnJ8_q4KblQVQGqhhIYq0oGtYDy_hk5_Xvx_DGWRcVqOCGvUtowxgWr1EtywpXgQrL6lLirie78HAPd3mEc0YR-P-HoDbU7HBacfZhocBSn2e98xIGOtvfGTznaDvk00SX56ZYi3Vkzh1h0mGxPMSXc09mau8n_Xuxr8sLhkOyb435Gbr58_nXxtbj-cXl1cX5dmIoBFMYBmqa2QnLXuKZn4JwA1qG1UvVYQ9ujqFTV1kKARcNda1wnK2xQGtHV4ox8OLy7jSGnTbMefTJ2yJXasCStmkYCU_KfIG8bwZWEDDYH0MSQUrROb6MfMe41Z3ptht7o1XO9eq7XZujHZuj7LH17zLF02bUn4dH9DLw_ApgMDi7iZHx64vJ_BRNrDZ8O3B8_2P1_F6C_nX9fo6x_d9A7DBpvY85x8xPWaeB5OGQL4gHiu6_y</recordid><startdate>20050101</startdate><enddate>20050101</enddate><creator>Esimone, C.O</creator><creator>Grunwald, T</creator><creator>Wildner, O</creator><creator>Nchinda, G</creator><creator>Tippler, B</creator><creator>Proksch, P</creator><creator>Uberla, K</creator><general>Blackwell Science Ltd</general><general>Blackwell Science</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7T7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20050101</creationdate><title>In vitro pharmacodynamic evaluation of antiviral medicinal plants using a vector-based assay technique</title><author>Esimone, C.O ; Grunwald, T ; Wildner, O ; Nchinda, G ; Tippler, B ; Proksch, P ; Uberla, K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5022-cf2ac87e341f8f8d02ff320baee46da729da356597332eac1f9cfb45a8a4c3b73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adenoviridae Infections - drug therapy</topic><topic>Adenoviruses, Human - genetics</topic><topic>Adenoviruses, Human - physiology</topic><topic>antiviral</topic><topic>Antiviral Agents - therapeutic use</topic><topic>antiviral properties</topic><topic>Biological and medical sciences</topic><topic>Biological Assay</topic><topic>Cell Line, Tumor</topic><topic>cultured cells</topic><topic>cytotoxicity</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genetic Engineering</topic><topic>genetic vectors</topic><topic>Genetic Vectors - administration & dosage</topic><topic>Genetic Vectors - genetics</topic><topic>HeLa Cells</topic><topic>HIV - genetics</topic><topic>HIV - physiology</topic><topic>HIV Infections - drug therapy</topic><topic>human health</topic><topic>Human immunodeficiency virus</topic><topic>Human immunodeficiency virus 1</topic><topic>Humans</topic><topic>lichen</topic><topic>Luciferases - genetics</topic><topic>Luminescent Measurements</topic><topic>medicinal plants</topic><topic>Medicine, African Traditional</topic><topic>Microbiology</topic><topic>Nigeria</topic><topic>pharmacodynamic</topic><topic>pharmacology</topic><topic>plant extracts</topic><topic>Plant Extracts - therapeutic use</topic><topic>Plants, Medicinal</topic><topic>Ramalina farinacea</topic><topic>Retroviridae - genetics</topic><topic>Retroviridae - physiology</topic><topic>vector‐based assay</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Esimone, C.O</creatorcontrib><creatorcontrib>Grunwald, T</creatorcontrib><creatorcontrib>Wildner, O</creatorcontrib><creatorcontrib>Nchinda, G</creatorcontrib><creatorcontrib>Tippler, B</creatorcontrib><creatorcontrib>Proksch, P</creatorcontrib><creatorcontrib>Uberla, K</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of applied microbiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Esimone, C.O</au><au>Grunwald, T</au><au>Wildner, O</au><au>Nchinda, G</au><au>Tippler, B</au><au>Proksch, P</au><au>Uberla, K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vitro pharmacodynamic evaluation of antiviral medicinal plants using a vector-based assay technique</atitle><jtitle>Journal of applied microbiology</jtitle><addtitle>J Appl Microbiol</addtitle><date>2005-01-01</date><risdate>2005</risdate><volume>99</volume><issue>6</issue><spage>1346</spage><epage>1355</epage><pages>1346-1355</pages><issn>1364-5072</issn><eissn>1365-2672</eissn><abstract>Aims: Medicinal plants are increasingly being projected as suitable alternative sources of antiviral agents. The development of a suitable in vitro pharmacodynamic screening technique could contribute to rapid identification of potential bioactive plants and also to the standardization and/or pharmacokinetic-pharmacodynamic profiling of the bioactive components. Methods and Results: Recombinant viral vectors (lentiviral, retroviral and adenoviral) transferring the firefly luciferase gene were constructed and the inhibition of viral vector infectivity by various concentrations of plant extracts was evaluated in HeLa or Hep2 cells by measuring the changes in luciferase activity. Cytotoxicity of the extracts was evaluated in parallel on HeLa or Hep2 cells stably expressing luciferase. Amongst the 15 extracts screened, only the methanol (ME) and the ethyl acetate (ET) fractions of the lichen, Ramalina farinacea specifically reduced lentiviral and adenoviral infectivity in a dose-dependent manner. Further, chromatographic fractionation of ET into four fractions (ET1-ET4) revealed only ET4 to be selectively antiviral with an IC50 in the 20 microgram ml(-1) range. Preliminary mechanistic studies based on the addition of the extracts at different time points in the viral infection cycle (kinetic studies) revealed that the inhibitory activity was highest if extract and vectors were preincubated prior to infection, suggesting that early steps in the lentiviral or adenoviral replication cycle could be the major target of ET4. Inhibition of wild-type HIV-1 was also observed at a 10-fold lower concentration of the extract. Conclusions: The vector-based assay is a suitable in vitro pharmacodynamic evaluation technique for antiviral medicinal plants. The technique has successfully demonstrated the presence of antiviral principles in R. farinacea. Significance and Impact of Study: Potential anti-HIV medicinal plants could rapidly be evaluated with the reported vector-based technique. The lichen, R. farinacea could represent a lead source of antiviral substances and is thus worthy of further studies.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science Ltd</pub><pmid>16313407</pmid><doi>10.1111/j.1365-2672.2005.02732.x</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1364-5072 |
ispartof | Journal of applied microbiology, 2005-01, Vol.99 (6), p.1346-1355 |
issn | 1364-5072 1365-2672 |
language | eng |
recordid | cdi_proquest_miscellaneous_68842064 |
source | MEDLINE; Oxford University Press Journals All Titles (1996-Current); Wiley Online Library All Journals |
subjects | Adenoviridae Infections - drug therapy Adenoviruses, Human - genetics Adenoviruses, Human - physiology antiviral Antiviral Agents - therapeutic use antiviral properties Biological and medical sciences Biological Assay Cell Line, Tumor cultured cells cytotoxicity Fundamental and applied biological sciences. Psychology Genetic Engineering genetic vectors Genetic Vectors - administration & dosage Genetic Vectors - genetics HeLa Cells HIV - genetics HIV - physiology HIV Infections - drug therapy human health Human immunodeficiency virus Human immunodeficiency virus 1 Humans lichen Luciferases - genetics Luminescent Measurements medicinal plants Medicine, African Traditional Microbiology Nigeria pharmacodynamic pharmacology plant extracts Plant Extracts - therapeutic use Plants, Medicinal Ramalina farinacea Retroviridae - genetics Retroviridae - physiology vector‐based assay |
title | In vitro pharmacodynamic evaluation of antiviral medicinal plants using a vector-based assay technique |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T15%3A26%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vitro%20pharmacodynamic%20evaluation%20of%20antiviral%20medicinal%20plants%20using%20a%20vector-based%20assay%20technique&rft.jtitle=Journal%20of%20applied%20microbiology&rft.au=Esimone,%20C.O&rft.date=2005-01-01&rft.volume=99&rft.issue=6&rft.spage=1346&rft.epage=1355&rft.pages=1346-1355&rft.issn=1364-5072&rft.eissn=1365-2672&rft_id=info:doi/10.1111/j.1365-2672.2005.02732.x&rft_dat=%3Cproquest_cross%3E68842064%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19831642&rft_id=info:pmid/16313407&rfr_iscdi=true |